天美传媒

The main aim of the Journal of Fibromyalgia: 天美传媒 Access is to publish high quality research works and provide 天美传媒 Access to the articles using this platform. The Journal offers a rapid and time bound review and publication that freely disseminates research findings related to fibromyalgia: open access. This journal caters to the requirements of the medical practitioners, researchers, lab professionals, students, academicians, and industry that is involved in Medical and clinical studies. No matter how prestigious or popular; it increases the visibility and impact of published work. It increases convenience, reach, and retrieval power. Free online literature software facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis

Fibromyalgia: 天美传媒 Access journal is an 天美传媒 Access publishing that aims to publish pathology, etiology, epidemiology of fibromyalgia. Articles on genetics, novel treatment approaches, preventive measures, diagnosis tests, causes and risk factors associated with fibromyalgia as original article, review articles, case reports, short communications, etc. related to fibromyalgia research and therapy are welcome.

All works published by OMICS International are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Fibromyalgia: 天美传媒 Access strongly supports the 天美传媒 Access initiative. All published articles will be assigned DOI provided by Cross Ref. This journal will keep up-to- date with latest advances in the field of food microbiology, safety & hygiene. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Fibromyalgia: 天美传媒 Access are freely accessible to everyone immediately after publication. Journal of Fibromyalgia: 天美传媒 Access diagnosis supports the Bethesda Statement on 天美传媒 Access Publishing.